Consultation on the Authorisation of 16 Regulated Products 2026

We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services. We also use cookies set by other sites to help us deliver content from their services. You have accepted additional cookies. You can change your cookie settings at any time. You have rejected additional cookies. You can change your cookie settings at any time. We are seeking stakeholders’ views in relation to the proposed authorisation of 16 novel foods. This consultation closes at 11:59pm on 16 November 2026 This page is also available in Welsh (Cymraeg) The UK Government is currently negotiating a Sanitary and Phytosanitary (SPS) Agreement with the European Union (EU). Under the proposed Agreement, the UK would align with all EU legislation within the scope of the Agreement, including market authorisations (subject to any exceptions being agreed during the negotiations with the EU). Once the Agreement enters into force, rules applying in Great Britain (GB) would be updated in line with EU rules as they changed over time. Products already authorised by the EU, and the conditions attached to those authorisations, would also apply in Great Britain (GB) once the Agreement enters into force. Existing GB authorisations would cease to apply. For further information Regulated products application guidance - GOV.UK Please note, we have completed our risk assessment of the products that are the subject of this consultation for use in the food categories for which applicants sought authorisation for in Great Britain (GB). Our risk management proposals, as detailed in the proposed terms of authorisation for each application reflect this, and may differ from those currently authorised in the European Union (EU). If there is an agreement to dynamically align with EU authorisations, those ingredients will not be permitted in the food categories that are not included in the EU authorisation. Furthermore, where the authorised food categories are the same in GB and the EU, the EU authorisation conditions - including any maximum use levels and other risk management measures - would apply in place of the corresponding GB authorisation conditions. All England, Wales, and Northern Ireland food businesses, local and port health authorities, district councils, and other stakeholders with an interest in food safety. A parallel consultation [Insert Link] is being published by Food Standards Scotland (FSS). This consultation seeks stakeholders’ views, comments, and feedback in relation to the regulated product applications considered in this document, which have been submitted for: 2’-Fucosyllactose (2’-FL) (produced by a derivative strain of Escherichia coli K-12) (modification of use of authorised novel food) 2’-Fucosyllactose/Difucosyllactose (2’-FL/DFL) mixture (produced by a derivative strain of Escherichia coli K-12 (DH1)) (modification of use of authorised novel food) 2’-Fucosyllactose (2’-FL) (produced by a derivative strain of Corynebacterium glutamicum (ATCC 13032)) as a novel food for use in food and food supplements (new authorisation of novel food) 2’-Fucosyllactose(2’-FL) (produced by a derivative strain of Escherichia coli BL21(DE3)) (modification of use of authorised novel food) 2’-Fucosyllactose (2’-FL) (produced by a derivative strain of Escherichia Coli BL21 (DE3)) (modification of specification of authorised novel food) 3′-Sialyllactose (3′-SL) sodium salt (produced by a derivative strain of Escherichia coli K-12 (DH1)) (modification of use of authorised novel food) 3’-Sialyllactose (3’-SL) sodium salt (produced by derivative strains of Escherichia coli BL21 (DE3)) as a novel food for use in food and food supplements (new authorisation of novel food) 3-Fucosyllactose (3-FL) (produced by a derivative strain of Escherichia coli K-12) (MG1655)) as a novel food for use in food and food supplements (new authorisation of novel food) 3-Fucosyllactose (3-FL) (